GSK-3 as potential target for therapeutic intervention in cancerJames A. McCubrey, Melchiorre Cervello, Antonino B. D’Assoro et al.|Oncotarget|2014Cited by 508
Deregulation of the EGFR/PI3K/PTEN/Akt/mTORC1 pathway in breast cancer: possibilities for therapeutic interventionNicole D. Armstrong, James A. McCubrey, Melissa L. Sokolosky et al.|Oncotarget|2014Cited by 246
Involvement of Akt-1 and mTOR in Sensitivity of Breast Cancer to Targeted TherapyMelissa L. Sokolosky, James A. McCubrey, Kristin M. Stadelman et al.|Oncotarget|2011Cited by 82